[Can 12- instead of 4‑weekly zoledronic acid administration reduce skeletal events in patients with bone metastases?]
- PMID: 28831507
- DOI: 10.1007/s00066-017-1191-0
[Can 12- instead of 4‑weekly zoledronic acid administration reduce skeletal events in patients with bone metastases?]
Comment on
-
Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.JAMA. 2017 Jan 3;317(1):48-58. doi: 10.1001/jama.2016.19425. JAMA. 2017. PMID: 28030702 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
